Our Commitment to the Environment
Boiron Group has a strong sense of obligation to respect the environment. The preparation of our products has a limited impact on the environment. The main effects derive from extracting raw materials (continuity of species gathered), water pollution (mainly organic and biodegradable) and waste. As a counterbalance, Boiron promotes re-supplying wild or organically-farmed plants when possible. This sequentially improves the quality of raw materials used. Additionally, Boiron works with botanist-harvesters well-versed in diagnosing the land and employing harvesting strategies to anticipate continuity of supplies for the future.
Our Commitment to Our Products
Unlike other pharmaceutical laboratories, Boiron produces its own active ingredients (plant-based mother tinctures with plants mainly sourced in France) as well as its main excipients, to increase quality and enhance traceability. Furthermore, Boiron has pharmaceutical sites throughout France which prepare and distribute medicines to dispensaries on a daily basis. Our intentional policy of maintaining production in France also involved the extension of the main production site in Messimy and the creation of a logistics platform in Les Olmes.
Wherever possible, Boiron uses local companies and service providers as well as working with local farmers for the Messimy and Sainte-Foy-lès-Lyon company canteens.
Boiron products are subject to the Good Manufacturing Practices (GMP) of pharmaceuticals and local regulations related to obtaining marketing authorizations or the registrations of homeopathic products, which leads to a high level of internal and external controls.
In addition, the pharmacovigilance processes in place within Boiron leads to the monitoring and declaration of any adverse side effects. Boiron provides a dedicated service team to pharmaceutical and medical information requests from healthcare professionals and customers.